by Adam Dick via Ron Paul Institute
Yet again. The United States government’s Food and Drug Administration (FDA) this week warned of a danger — this time the bleeding disorder immune thrombocytopenia — from Johnson & Johnson’s experimental coronavirus vaccine shot, while, as usual, remaining silent about dangers from competing shots from Moderna and Pfizer-BioNTech.
The apparent regulatory favoritism for these competitors’ mRNA technology shots continues.
Oh well. Anyone who, at this point, expects objective decisions from US government agencies regarding coronavirus related matters has not been paying close attention. It’s a scam through and through.
I have written here, here, and here about previous instances of apparent favoritism by US government regulators for Moderna and Pfizer-BioNTech shots over the Johnson & Johnson shot.
Copyright © 2022 by RonPaul Institute.
Reprinted with permission from RonPaul Institute.